We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-1.37%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.2B
AUM Growth
+$2.05B
Cap. Flow
+$2.63B
Cap. Flow %
18.56%
Top 10 Hldgs %
24.41%
Holding
915
New
139
Increased
425
Reduced
186
Closed
46

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$226M
2
MSFT icon
Microsoft
MSFT
+$205M
3
TSLA icon
Tesla
TSLA
+$83.2M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$65.6M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$64.9M

Top Sells

Rank Stock Value
1
SQM icon
Sociedad Química y Minera de Chile
SQM
+$60.4M
2
META icon
Meta Platforms (Facebook)
META
+$39.1M
3
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$36.9M
4
BKNG icon
Booking.com
BKNG
+$28M
5
SYK icon
Stryker
SYK
+$25.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.77%
2 Technology 24.47%
3 Financials 9.64%
4 Consumer Discretionary 7.95%
5 Industrials 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVB icon
226
AvalonBay Communities
AVB
$27.5B
$12.4M 0.09%
67,225
+24,372
+57% +$4.92M
BAP icon
227
Credicorp
BAP
$30.5B
$12.3M 0.09%
99,800
+8,240
+9% +$1.06M
HASI icon
228
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.81B
$12.3M 0.09%
409,286
-11,851
-3% -$442K
JEF icon
229
Jefferies Financial Group
JEF
$12.7B
$12.2M 0.09%
432,171
+157,918
+58% +$4.78M
RMD icon
230
ResMed
RMD
$31.1B
$12.1M 0.09%
55,347
+19,349
+54% +$4.4M
URI icon
231
United Rentals
URI
$65.7B
$12M 0.08%
44,521
+3,295
+8% +$959K
KYMR icon
232
Kymera Therapeutics
KYMR
$8.66B
$12M 0.08%
549,618
+79,758
+17% +$2.1M
CLDX icon
233
Celldex Therapeutics
CLDX
$2.94B
$11.8M 0.08%
418,509
+127,715
+44% +$3.92M
LH icon
234
Labcorp
LH
$25.2B
$11.8M 0.08%
66,826
+16,114
+32% +$3.3M
REG icon
235
Regency Centers
REG
$14.9B
$11.6M 0.08%
215,818
+13,118
+6% +$802K
TGT icon
236
Target
TGT
$66.3B
$11.6M 0.08%
78,124
-94,902
-55% -$15.2M
GPK icon
237
Graphic Packaging
GPK
$3.35B
$11.5M 0.08%
580,816
+303,523
+109% +$6.66M
CVET
238
DELISTED
Covetrus, Inc. Common Stock
CVET
$11.4M 0.08%
547,953
-75,230
-12% -$1.57M
CERE
239
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$11.2M 0.08%
397,221
– –
CCK icon
240
Crown Holdings
CCK
$13B
$11.2M 0.08%
138,032
-63,213
-31% -$5.89M
AGO icon
241
Assured Guaranty
AGO
$3.73B
$11.2M 0.08%
+230,360
New +$12.4M
SYK icon
242
Stryker
SYK
$135B
$11.1M 0.08%
54,704
-119,724
-69% -$25.2M
CEVA icon
243
CEVA Inc
CEVA
$831M
$11M 0.08%
419,323
– –
DGX icon
244
Quest Diagnostics
DGX
$26B
$11M 0.08%
89,582
+28,936
+48% +$3.81M
DNLI icon
245
Denali Therapeutics
DNLI
$3.79B
$11M 0.08%
357,878
+34,996
+11% +$1.14M
TRU icon
246
TransUnion
TRU
$16B
$10.9M 0.08%
183,771
+110,869
+152% +$8.53M
AXS icon
247
AXIS Capital
AXS
$7.81B
$10.9M 0.08%
+222,273
New +$11.8M
KEY icon
248
KeyCorp
KEY
$23.8B
$10.9M 0.08%
680,573
+9,944
+1% +$178K
MAT icon
249
Mattel
MAT
$4.47B
$10.9M 0.08%
574,289
+279,926
+95% +$6.26M
PGR icon
250
Progressive
PGR
$128B
$10.9M 0.08%
93,602
+55,202
+144% +$6.65M
8 9
10
11 12

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2022 Portfolio in Review

As of Q3 2022, Candriam SCA held 915 positions worth $14.2B, up 17% from $12.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA deployed $2.63B of net new capital in Q3 2022, opening 139 new positions and adding to 425 existing holdings. Its largest new stake was Veru: 378,115 shares worth $43.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Sociedad Química y Minera de Chile, an estimated $60.4M trimmed.

  • Candriam SCA's largest Q3 2022 buy was Veru: 378,115 shares worth $43.6M.
  • Candriam SCA added most to Apple in Q3 2022, an estimated $226M increase.
  • Candriam SCA's biggest Q3 2022 reduction was Sociedad Química y Minera de Chile, cutting an estimated $60.4M.
  • Candriam SCA fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $36.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.2B portfolio in Q3 2022.
  • Candriam SCA opened 139 new positions and closed 46 in Q3 2022.
  • Candriam SCA's portfolio value rose 17% quarter-over-quarter to $14.2B.

Based on Candriam SCA's 13F filing for Q3 2022, filed 10 Nov 2022.